Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer
Latest Information Update: 16 May 2025
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- Acronyms PROSPETMR2021
Most Recent Events
- 08 May 2025 Planned End Date changed from 30 Nov 2024 to 31 Mar 2026.
- 08 May 2025 Planned primary completion date changed from 30 Apr 2024 to 31 Jan 2026.
- 21 Sep 2023 Status changed from not yet recruiting to recruiting.